Baxter erects global R&D center at Syngene

Biocon’s research wing and CRO, Syngene and US-based pharmaceutical company, Baxter International, have collaborated to establish Baxter Global Research Center (BGRC) at Syngene, Bangalore.


The R&D center was inaugurated by Shri Ghulam Nabi Azad, Honorable Minister of Health and Family Welfare, Government of India.

This initiative is a part of Baxter's global strategy of building its R&D collaborations.

A workforce comprising of 100 scientists and experts is expected to do R&D at this center, focusing on product development, analytical and pre-clinical solutions.

In his speech, Shri Ghulam Nabi Azad commented, "There are several opportunities available for producing immunomodulators for the treatment of immune-deficient diseases, cancer and other non-communicable diseases (NCDs) by the application of modern biotechnology and nanotechnology."

Talking about the country's regulatory mechanism, he said, "At the government level, we are working towards improving regulatory processes. We should have a transparent regulatory mechanism but not at the cost of new innovations. We do not want to kill innovation. We want innovations to happen in our country."


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email